Author;Study location;QUADAS;Independent;Sample condition;Sample type;Sample size;Sensitivity (95% CI);Specificity (95% CI)
AAZ, COVID-VIRO®;;;;;;;;
Schwob, J.M., et al.;Switzerland;low concern;yes;fresh;NP;248;96.7% (95% CI 91.8*-99.1*);100% (95% CI 97.1*-100*)
;;;;;;;;
Abbott, BinaxNOW™;;;;;;;;
Pollock, N.R., et al.;USA;low concern;yes;fresh;AN;2308;78.1% (95% CI 77.4-72.2);99.4% (95% CI 99.0-99.7)
Pilarowski, G., et al.;USA;low concern;no;fresh;AN;878;57.7% (95% CI 36.9*-76.7*);100%* (95% CI 99.6*-100*)
James, A. E., et al.;USA;low concern;yes;fresh;AN;2339;56.5% (95% CI 48.7-64.5);99.9% (95% CI 99.7-100)
Okoye, N.C., et al.;USA;intermediate concern;unclear;fresh;MT;2645;53.3% (95% CI 39.1-67.1);100% (95% CI 99.9-100)
;;;;;;;;
Abbott, Panbio™ (NP sampling);;;;;;;;
Domínguez Fernández, M., et al.;Spain;intermediate concern;unclear;fresh;unclear;30;95.0% (not provided);100% (not provided)
Alemany, A., et al.;Spain;intermediate concern;yes;banked;NP;919;93.4% (95% CI 91.5-95.0);100% (95% CI 95.8-100)
FINDdx;Germany;low concern;yes;fresh;NP;281;90.9% (95% CI 78.8-96.4);99.2% (95% CI 97.0-99.8)
Merino-Amador, P., et al.;Spain;low concern;no;fresh;NP;958;90.5% (95% CI 87.5-93.6);98.8% (95% CI 98.0-99.7)
Krüger, L.J., et al.;Germany;low concern;yes;fresh;NP;1034;87.5% (95% CI 79.8-92.5);99.9% (95% CI 99.4-100)
Schwob, J.M., et al.;Switzerland;low concern;yes;fresh;NP;271;86.1% (95% CI 78.6-91.7);100% (95% CI 97.6*-100*)
Stokes, W., et al.;Canada;low concern;yes;fresh;NP;1641;86.1% (95% CI 81.3-90.0);99.9% (95% CI 99.5-100)
Berger, A., et al.;Switzerland;low concern;yes;fresh;NP;535;85.5% (95% CI 78.0-91.2);100% (95% CI 99.1-100)
Faíco-Filho, K.S., et al.;Brazil;low concern;no;fresh;NP;127;84.0% (95% CI 75.0-93.8);98.0% (95% CI 96.0-98.8)
Jääskeläinen, A.E., et al.;Finland;high concern;yes;banked;NP;190;83.0% (95% CI 76.1-88.1);100% (not provided)
Abdulrahman, A., et al.;Bahrain;intermediate concern;yes;fresh;AN;4183;82.1% (95% CI 79.2-84.8);99.1% (95% CI 98.8-99.4)
Gremmels, H., et al.;Netherlands;intermediate concern;yes;fresh;NP;208;81.0% (95% CI 69.0-89.9);100% (95% CI 97.5-100)
Ngo Nsoga, M.T., et al.;Switzerland;intermediate concern;yes;fresh;OP;402;81.0% (95% CI 74.2-86.6);99.1% (95% CI 96.9-99.9)
Albert, E., et al.;Spain;low concern;no;fresh;NP;412;79.6% (95% CI 67.0-88.8);100% (95% CI 98.7-100)
Alemany, A., et al.;Spain;intermediate concern;yes;banked;MT;487;79.5% (95% CI 71.0-86.4);98.7% (95% CI 96.9-99.6)
Fenollar, F., et al.;France;low concern;yes;fresh;NP;341;75.5% (95% CI 69.5-81.5);94.9% (95% CI 91.2-98.6)
Linares, M., et al.;Spain;unclear;yes;fresh;NP;255;73.3% (95% CI 62.2-83.8);100% (95% CI 98.1*-100*)
Gremmels, H., et al.;Netherlands;intermediate concern;yes;fresh;NP;1367;72.6% (95% CI 64.5-79.9);100% (95% CI 99.7-100)
Halfon, P. et al.;France;intermediate concern;yes;unclear;NP;200;72.0% (95% CI 62.0-81.0);99.0% (95% CI 95.0-100)
Bulilete, O., et al.;Spain;low concern;yes;fresh;NP;1362*;71.4% (95% CI 63.2*-78.7);99.8% (95% CI 99.4-99.9)
Akingba, O.L., et al.;Southafrica;unclear;yes;fresh;NP;677;69.2% (95% CI 61.4-75.8);99.0% (95% CI 98.8-99.2)
Del Vecchio, C., et al.;Italy;low concern;yes;fresh;unclear;1441;68.9% (95% CI 55.7-80.1);99.9% (95% CI 99.6-100)
Favresse, J., et al.;Belgium;intermediate concern;yes;fresh;NP;188;67.7% (95% CI 57.4-76.9);100% (95% CI 96.1-100)
Drevinek, P., et al.;Czech Republic;low concern;yes;fresh;NP;591;66.4% (95% CI 59.9-72.2);100% (95% CI 99.0-100)
Pérez-García, F., et al.;Spain;high concern;no;banked;NP;320;60.0% (95% CI 52.2-67.4);100% (95% CI 97.6-100)
Agullo, V., et al.;Spain;low concern;yes;fresh;NP;652*;57.3% (95% CI 48.3-65.8);99.8% (95% CI 98.8-100)
Schildgen, V., et al.;Germany;high concern;yes;unclear;BAL/TW;73;50.0% (95% CI 34.2*-65.8*);77.4% (95% CI 58.9*-90.4*)
Krüger, L.J., et al.;Germany;high concern;yes;fresh;OP;74;50.0% (95% CI 1.3-98.7);100% (95% CI 94.9-100)
Torres, I., et al.;Spain;low concern;no;fresh;NP;634;48.1% (95% CI 37.4-58.9);100% (95% CI 99.3-100)
Villaverde, S., et al.;Spain;intermediate concern;yes;fresh;NP;1620;45.4% (95% CI 34.1-57.2);99.8% (95% CI 99.4-99.9)
Agullo, V., et al.;Spain;intermediate concern;yes;fresh;AN;659;44.7% (95% CI 36.1-53.6);100% (95% CI 99.1-100)
Olearo, F., et al.;Germany;intermediate concern;yes;unclear;OP;184;44.6% (95% CI 34.3-55.3);100% (95% CI 96.3-100)
Caruana, G., et al.;Switzerland;intermediate concern;yes;fresh;NP;532;41.2% (not provided);99.5% (not provided)
Baro, B., et al.;Spain;intermediate concern;yes;banked;NP;286;38.6% (95% CI 29.1-48.8);99.5% (95% CI 97-100)
Agullo, V., et al.;Spain;intermediate concern;yes;fresh;saliva;610;23.1% (95% CI 16.2-31.9);100% (95% CI 99.0-100)
;;;;;;;;
Abbott, Panbio™ (nasal sampling);;;;;;;;
FINDdx;Germany;low concern;yes;fresh;AN/MT;281;86.4% (95% CI 73.3-93.9);99.2% (95% CI 97-99.8)
;;;;;;;;
Access Bio, CareStart™ COVID-19 Antigen Test;;;;;;;;
Pollock, N.R., et al.;USA;low concern;yes;fresh;AN;1498;57.7% (95% CI 51.1-64.1);98.3% (95% CI 97.5-99.0)
;;;;;;;;
Becton, Dickinson and Company, BD Veritor™;;;;;;;;
Pekosz, A., et al.;USA;high concern;no;fresh;NP;251;"96.4% (95% CI 82.3-99.4)
compared to virus culture";"98.7% (95% CI 96.1-99.7)
compared to virus culture"
Van der Moeren, N., et al.;Netherlands;intermediate concern;yes;banked;NP/OP;351*;94.1% (95% CI 71.1-100);100% (95% CI 98.9-100)
Marti, J.L.G., et al.;USA;unclear;yes;fresh;AN;unknown;93.8% (not provided);100% (not provided)
Young, S., et al.;USA;intermediate concern;no;banked;NP;251;76.3%* (95% CI 60.8*-87.0*);99.5%* (95% CI 97.4*-99.9*)
Schuit, E., et al.;Netherlands;intermediate concern;yes;fresh;NP;2678;63.9% (95% CI 57.4-70.1);99.6% (95% CI 99.3-99.8)
Caruana, G., et al.;Switzerland;intermediate concern;yes;fresh;NP;532;41.2% (not provided);99.7% (not provided)
;;;;;;;;
Becton, Dickinson and Company, Hometest;;;;;;;;
Stohr, J.J.J.M., et al.;Netherlands;low concern;yes;fresh;AN;1604;48.9% (95% CI 41.6-56.2);99.9% (95% CI 995.-100)
;;;;;;;;
Beijing Savant Biotechnology, SARS-CoV-2 detection kit;;;;;;;;
Weitzel, T., et al.;Chile;high concern;no;banked;NP/OP;109;16.7% (95% CI 10.0-26.5*);100% (95% CI 89.0-100)
;;;;;;;;
Bionote, NowCheck®;;;;;;;;
FINDdx;Brazil;low concern;yes;fresh;NP;400;89.2% (95% CI 81.7-93.9);97.3% (95% CI 94.8-98.6)
Rottenstreich, A., et al.;Israel;low concern;yes;unclear;NP;1326;55.6% (95% CI 21.2-86.3);100% (95% CI 99.7-100)
;;;;;;;;
Biotical Health, SARS-CoV-2 Ag Card;;;;;;;;
Favresse, J., et al.;Belgium;intermediate concern;yes;fresh;NP;188;66.7% (95% CI 56.3-76.0);98.8% (95% CI 94.1-99.9)
;;;;;;;;
CerTest Biotec, SARS-CoV-2 one step test card;;;;;;;;
Pérez-García, F., et al.;Spain;high concern;no;banked;NP;320;53.5% (95% CI 45.7-61.2);100% (95% CI 97.6-100)
;;;;;;;;
Coris BioConcept, COVID-19 Ag Respi-Strip;;;;;;;;
Mertens, P., et al.;Belgium;intermediate concern;no;banked;NP;328;57.6% (95% CI 48.7*-66.1*);99.5% (95% CI 97.2*-100*)
Lambert-Niclot, S., et al.;France;unclear;yes;fresh;NP;138;50.0% (95% CI 39.5-60.5);100% (95% CI 91.8-100)
Krüger, L.J., et al.;Germany/England;intermediate concern;yes;unclear;NP/OP;417;50.0% (95% CI 21.5-78.5);95.8% (95% CI 93.4-97.4)
Ciotti, M., et al.;Italy;unclear;yes;fresh;NP;50;30.8% (95% CI 17.0-47.6);100% (95% CI 71.5-100)
Scohy, A., et al.;Belgium;intermediate concern;no;fresh;NP;148;30.2% (95% CI 21.7-39.9);100% (95% CI 91.6*-100*)
Veyrenche, N., et al.;France;high concern;yes;fresh;NP;65;29.0% (95% CI 15.7-42.3);100% (95% CI 83.2*-100*)
;;;;;;;;
Denka, Quick Navi;;;;;;;;
Takeuchi, Y., et al.;Japan;low concern;no;fresh;NP;1186;86.7% (95% CI 78.6-92.5);100% (95% CI 99.7-100)
Takeuchi, Y., et al.;Japan;unclear;no;fresh;AN;862;71.5% (95% CI 58.3-84.1);100% (95% CI 99.3-100)
;;;;;;;;
EcoDiagnostica, COVID-19 Ag;;;;;;;;
Filgueiras, P.S., et al.;Brazil;unclear;no;fresh;NP;150;69.0% (95% CI 55.0-81.0);98.0% (95% CI 94.0-100)
;;;;;;;;
Fujirebio, ESPLINE® SARS-CoV-2;;;;;;;;
Takeda, Y., et al.;Japan;high concern;no;unclear;NP;162;80.7%* (95% CI 68.6*-89.6*);100%* (95% CI 96.4*-100*)
Yokota, I., et al.;Japan;high concern;no;banked;NP;17;58.8%* (95% CI 32.9*-81.6*);not provided
Yokota, I., et al.;Japan;high concern;no;banked;saliva;17;23.5%* (95% CI 6.8*-49.9*);not provided
;;;;;;;;
Fujirebio, Lumipulse® G SARS-CoV-2 Ag;;;;;;;;
Gili, A., et al.;Italy;intermediate concern;yes;banked;NP;226;100% (95% CI 96.0-100);94.8% (95% CI 93.6-95.8)
Yokota, I., et al.;Japan;high concern;no;banked;NP;17;100% (95% CI 80.5*-100);not provided
Gili, A., et al.;Italy;intermediate concern;yes;fresh;NP;1738;92.6% (95% CI 85.4-97.0);90.8% (95% CI 84.5-95.2)
Yokota, I., et al.;Japan;high concern;no;banked;saliva;17;82.4%* (95% CI 56.6*-96.2*);not provided
Basso, D., et al.;Italy;low concern;yes;fresh;NP;234;81.6% (95% CI 71.0-89.5);93.8% (95% CI 86.2-98.0)
Menchinelli, G., et al.;Italy;intermediate concern;yes;banked;NP;594;79.9% (95% CI 73.6-85.3);99.3% (95% CI 97.8-99.8)
Basso, D., et al.;Italy;low concern;yes;fresh;saliva;223;41.3% (95% CI 30.4-52.8);98.6% (95% CI 95.0-99.8)
;;;;;;;;
Guangzhou Wondfo Biotech, 2019-nCoV Antigen Test;;;;;;;;
FINDdx;Switzerland;low concern;yes;fresh;NP;328;85.7% (95% CI 74.3-92.6);100% (95% CI 98.6-100)
;;;;;;;;
Healgen, Rapid COVID-19 Ag Test;;;;;;;;
Favresse, J., et al.;Belgium;intermediate concern;yes;fresh;NP;188;77.1% (95% CI 67.4-85.1);96.7% (95% CI 90.8-99.3)
;;;;;;;;
ichroma, COVID-19 AG;;;;;;;;
FINDdx;Switzerland;low concern;yes;fresh;NP;232;73.2% (95% CI 58.1-84.3);100% (95% CI 98.0-100)
;;;;;;;;
Innova Medical Group, INNOVA SARS-CoV-2 Antigen Rapid Qualitative Test;;;;;;;;
Houston, H., et al.;United Kingdom;low concern;yes;fresh;NP;242;86.4% (CI 95% 81.1-90.0);95.1% (CI 95% 92.6-96.7)
Peto, T., et al.;United Kingdom;unclear;yes;unclear;unclear;6954;not provided;99.7% (not provided)
Peto, T., et al.;United Kingdom;unclear;yes;unclear;unclear;198;78.8% (95% CI 72.4-84.3);not provided
Peto, T., et al.;United Kingdom;unclear;yes;unclear;unclear;223;70.0% (95% CI 63.5-75.9);not provided
Young, B.C., et al.;United Kingdom;unclear;yes;fresh;NP;803;62.4% (95% CI 55.6-69.0);100% (95% CI 99.4-100)
Peto, T., et al.;United Kingdom;unclear;yes;unclear;unclear;372;57.5% (95% CI 52.3-62.6);not provided
;;;;;;;;
JOYSBIO Biotechnology, COVID-19 Antigen Rapid Test Kit;;;;;;;;
FINDdx;Switzerland;low concern;yes;fresh;NP;265;70.5% (95% CI 55.8-81.8);99.1% (95% CI 96.8-99.8)
;;;;;;;;
Lepu Medical, SARS-CoV-2 Antigen Rapid Test Kit;;;;;;;;
Baro, B., et al.;Spain;intermediate concern;yes;banked;NP;286;45.5% (95% CI 35.6-55.8);89.2% (95% CI 83.8-93.3)
;;;;;;;;
Liming Bio, SARS-CoV-2 Ag-RDT;;;;;;;;
Weitzel, T., et al.;Chile;high concern;no;banked;NP/OP;19;0.0% (95% CI 0.0-29.9);90.0% (95% CI 59.6-98.2)
;;;;;;;;
LumiraDx, COVID-19 SARS-CoV-2 Antigen Test;;;;;;;;
Drain, P.K., et al.;UK/US;low concern;no;fresh;AN;257;97.6% (95% CI 91.6-99.3);96.6% (95% CI 92.7-98.4)
Drain, P.K., et al.;UK/US;low concern;no;fresh;NP;255;97.5% (95% CI 87.1-99.0);97.7% (95% CI 94.7-99.0)
Krüger, L.J., et al.;Germany;low concern;yes;fresh;MT;761;82.2% (95% CI 75.2-87.5);99.3% (95% CI 98.3-99.7)
Kohmer, N., et al.;Germany;intermediate concern;yes;fresh;NP;100;50.0% (95% CI 38.1-61.9);100% (95% CI 86.8-100)
;;;;;;;;
MEDsan®, SARS-CoV-2 Antigen Rapid Test;;;;;;;;
Olearo, F., et al.;Germany;intermediate concern;yes;unclear;OP;184;45.8% (35.5%-56.5%);97.0% (91.5%-98.9%)
;;;;;;;;
NAL von minden, NADAL;;;;;;;;
Strömer, A., et al.;Germany;high concern;yes;banked;NP;124;73.1% (not provided);not provided
Kohmer, N., et al.;Germany;intermediate concern;yes;fresh;NP;100;24.3% (95% CI 15.1-35.7);100% (95% CI 86.8-100)
;;;;;;;;
Ortho Clinical Diagnostics, VITROS® SARS-CoV-2 Antigen Test;;;;;;;;
Favresse, J., et al.;Belgium;intermediate concern;yes;fresh;NP;188;83.3% (95% CI 74.4-90.2);100% (95% CI 96.1-100)
;;;;;;;;
Precision Biosensors, Exdia COVID-19 Ag;;;;;;;;
Caruana, G., et al.;Switzerland;intermediate concern;yes;fresh;NP;532;48.3% (not provided);99.5% (not provided)
;;;;;;;;
QUIDEL, Sofia SARS Antigen FIA;;;;;;;;
Porte, L., et al.;Chile;high concern;no;banked;NP/OP;64;93.8% (95% CI 79.9-98.3);96.9% (95% CI 84.3-99.4)
Jääskeläinen, A.E., et al.;Finland;high concern;yes;banked;NP;188;80.0% (95% CI 73.3-86.0);100% (not provided)
Beck, E.T., et al.;USA;intermediate concern;yes;fresh;NP;346;77.0% (95% CI 64.5*-86.9*);99.6% (95% CI 98.1*-100*)
Herrera, V., et al.;USA;unclear;yes;unclear;unclear;1172;76.8% (95% CI 72.6-80.5);99.2% (95% CI 98.2-99.7)
Marti, J.L.G., et al.;USA;unclear;yes;fresh;MT;427;72.0% (not provided);99.0% (not provided)
;;;;;;;;
RapiGEN, Biocredit Covid-19 Antigen Detection Kit;;;;;;;;
Shidlovskaya, E., et al.;Russia;low concern;yes;fresh;NP;106;"100% (95% CI 76.8-100)
compared to virus culture";"67.4% (95% CI 56.8-76.8)
compared to virus culture"
Shrestha, B., et al.;Nepal;intermediate concern;yes;fresh;NP;113;85.0% (95% CI 71.7*-93.8*);100% (95% CI 94.6*-100*)
FINDdx;Brazil;low concern;yes;fresh;NP;476;74.4% (95% CI 65.8-81.4);99.0% (95% CI 97.2-99.6)
Weitzel, T., et al.;Chile;high concern;no;banked;NOP;109;62.0% (95% CI 51.0-71.9);100% (95% CI 88.7-100)
Shidlovskaya, E., et al.;Russia;low concern;yes;fresh;NP;106;56.4% (95% CI 44.7-67.6);100% (95% CI 87.7-100)
Schildgen, V., et al.;Germany;high concern;yes;unclear;BAL/TW;73;33.3% (95% CI 19.6*-49.6*);87.1% (95% CI 70.2*-94.6*)
;;;;;;;;
R-Biopharm, RIDA®QUICK SARS-CoV-2 Antigen;;;;;;;;
Toptan, T., et al.;Germany;intermediate concern;no;banked;unclear;67;77.6% (95% CI 64.7*-87.5*);100% (95% CI 66.4*-100*)
Toptan, T., et al.;Germany;unclear;no;banked;NP/OP;70;50.0% (95% CI 31.9*-68.1*);100% (95% CI 90.8*-100*)
Kohmer, N., et al.;Germany;intermediate concern;yes;fresh;NP;100;39.2% (95% CI 28.0-51.2);96.2% (95% CI 80.4-99.9)
;;;;;;;;
Salofa, Salocor SARS-CoV-2 Antigen;;;;;;;;
Ahava, M.J., et al.;Finland;high concern;yes;frozen;serum;148;96.2% (95% CI 80.4-99.9);98.0% (95% CI 94.2-99.6)
;;;;;;;;
SD Biosensor, Standard F;;;;;;;;
Porte, L., et al.;Chile;high concern;no;banked;NP/OP;64;90.6% (95% CI 75.8-96.8);96.9% (95% CI 84.3-99.4)
FINDdx;Brazil;low concern;yes;fresh;NP;453;77.5% (95% CI 69.2-84.1);97.9% (95% CI 95.7-99.0)
Drevinek, P., et al.;Czech Republic;low concern;yes;fresh;NP;591;62.3% (95% CI 55.8-68.4);99.5% (95% CI 98.0-99.9)
Osterman, A., et al.;Germany;high concern;yes;unclear;NP/OP;360;60.9% (95% CI 53.7-67.5);97.8% (95% CI 95.7-98.9)
Liotti, F.M., et al.;Italy;intermediate concern;yes;banked;NP;359;47.1% (95% CI 37.1-57.1);98.4% (95% CI 96.0-99.6)
;;;;;;;;
SD Biosensor / Roche, Standard Q (NP sampling);;;;;;;;
Chaimayo, C., et al.;Thailand;intermediate concern;yes;banked;NP/OP;454;98.3% (95% CI 91.1-100);98.7% (95% CI 97.1-99.6)
Schwob, J.M., et al.;Switzerland;low concern;yes;fresh;NP;333;92.9% (95% CI 86.4-96.9);100% (95% CI 98.3*-100*)
Nikolai, O., et al.;Germany;low concern;yes;fresh;NP;96;91.2% (95% CI 77.0-97.0);100% (95% CI 94.2-100)
Berger, A., et al.;Switzerland;low concern;yes;fresh;NP;529;89.0% (95% CI 83.7-93.1);99.7% (95% CI 98.4-100)
FINDdx;Brazil;low concern;yes;fresh;NP;400;88.7% (95% CI 81.3-93.4);97.6% (95% CI 95.2-98.8)
Schildgen, V., et al.;Germany;high concern;yes;unclear;BAL/TW;73;88.1% (95% CI 74.4*-96.0*);19.4% (95% CI 7.5*-37.5*)
Lindner, A.K., et al.;Germany;low concern;yes;fresh;NP;139;85.0% (955 CI 70.9-92.9);99.1% (95% CI 94.8-99.5)
Iglὁi, Z., et al.;Netherlands;low concern;yes;fresh;NP;970;84.9% (95% CI 79.1-89.4);99.5% (95% CI 98.7-99.8)
Gupta, A., et al.;India;low concern;yes;fresh;NP;330;81.8% (95% CI 71.3-89.6);99.6% (95% CI 97.8-99.9)
Jääskeläinen, A.E., et al.;Finland;high concern;yes;banked;NP;198;81.0% (95% CI 74.2-86.4);100% (not provided)
Turcato, G., et al.;Italy;unclear;unclear;fresh;NP;3410;80.3% (95% CI 74.9-85.4);99.1% (95% CI 98.6-99.3)
Lindner, A.K., et al.;Germany;low concern;yes;fresh;NP;289;79.5% (95% CI 64.5-89.2);99.6% (95% CI 97.8-100)
Krüger, L.J., et al.;Germany/England;intermediate concern;yes;unclear;NP/OP;1263;76.6% (95% CI 62.8-86.4);99.3% (95% CI 98.6-99.6)
Möckel, M., et al.;Germany;intermediate concern;yes;fresh;NP/OP;271;75.3% (95% CI 65.8-83.4);100% (95% CI 98.4-100)
Lindner, A.K., et al.;Germany;intermediate concern;yes;fresh;AN;289;74.4% (95% CI 58.9-85.4);99.2% (95% CI 97.1-99.8)
Lindner, A.K., et al.;Germany;low concern;yes;fresh;NP;180;73.0% (95% CI 58.1-84.3);99.3% (95% CI 96.0-100)
Salvagno, G.L., et al.;Italy;intermediate concern;yes;unclear;NP;321;72.5% (95% CI 64.6-79.5);99.4% (95% CI 96.8-100)
Cerutti, F., et al.;Italy;unclear;yes;unclear;NP;185;72.1% (95% CI 62.5*-80.5*);100% (95% CI 95.6*-100*)
Möckel, M., et al.;Germany;intermediate concern;yes;fresh;NP/OP;2020;72.0% (95% CI 53.3-86.7);99.4% (95% CI 97.3-99.9)
Krüttgen, A., et al.;Germany;high concern;yes;banked;NP;150;70.7% (95% CI 59.0*-80.6*);96.0% (95% CI 88.9*-99.2*)
Nalumansi, A., et al.;Uganda;low concern;yes;fresh;NP;262;70.0% (95% CI 60.0-79.0);92.0% (95% CI 87.0-96.0)
Pena, M., et al.;Chile;low concern;yes;fresh;NP;842;69.8% (95% CI 58.5-79.2);99.6% (95% CI 98.86-99.87)
Favresse, J., et al.;Belgium;intermediate concern;yes;fresh;NP;188;69.8% (95% CI 59.6-78.8);100% (95% CI 96.1-100)
Osterman, A., et al.;Germany;high concern;yes;unclear;NP/OP;386;64.5% (95% CI 58.4-70.1);97.7% (95% CI 95.6-98.8)
Schuit, E., et al.;Netherlands;low concern;yes;fresh;NP;1596;62.9% (95% CI 54.0-71.1);99.5% (95% CI 98.9-99.8)
Ristic, M., et al.;Serbia;low concern;yes;fresh;NP;120;58.1% (95% CI 42.1-73.0);100% (not provided)
Kannian, P., et al.;India;high concern;yes;unclear;saliva;37;56.0% (not provided);100% (not provided)
Olearo, F., et al.;Germany;intermediate concern;yes;unclear;OP;184;49.4% (95% CI 38.9-59.9);100% (95% CI 96.3-100)
Baro, B., et al.;Spain;intermediate concern;yes;banked;NP;286;43.6% (95% CI 33.7-53.8);96.2% (95% CI 92.4-98.5)
Kohmer, N., et al.;Germany;intermediate concern;yes;fresh;NP;100;43.2% (95% CI 37.8-55.3);100% (95% CI 86.8-100)
Caruana, G., et al.;Switzerland;intermediate concern;yes;fresh;NP;532;41.2% (not provided);99.7%  (not provided)
Cerutti, F., et al.;Italy;unclear;yes;fresh;NP;145;40.0% (95% CI 5.3*-85.3*);100% (95% CI 97.4*-100*)
;;;;;;;;
SD Biosensor / Roche, Standard Q (nasal sampling);;;;;;;;
Nikolai, O., et al.;Germany;low concern;yes;fresh;MT;96;91.2% (95% CI 77.0-97.0);100% (95% CI 94.2-100)
Nikolai, O., et al.;Germany;low concern;yes;fresh;MT;132;86.1% (95% CI 71.3-93.9);100% (95% CI 89.0-100)
Nikolai, O., et al.;Germany;low concern;yes;fresh;AN;132;86.1% (95% CI 71.3-93.9);100% (95% CI 89.0-100)
Linder, A.K., et al.;Germany;low concern;yes;fresh;MT;180;80.5% (95% CI 66-89.8);98.6% (95% CI 94.9-99.6)
Stohr, J.J.J.M., et al.;Netherlands;low concern;yes;fresh;AN;1611;61.5% (95% CI 54.4-68.1);99.7% (95% CI 99.3-99.9)
;;;;;;;;
Shenzen Bioeasy Biotechnology, 2019-nCov Antigen Rapid Test Kit;;;;;;;;
Porte, L., et al.;Chile;high concern;yes;banked;NP/OP;127;93.9% (95% CI 86.5-97.4);100% (95% CI 92.1*-100*)
Weitzel, T., et al.;Chile;high concern;no;banked;NP/OP;111;85.0% (95% CI 75.6-91.2);100% (95% CI 89.0-100)
Parada-Ricart, E., et al.;Spain;intermediate concern;yes;fresh;NP;172;73.1%* (95% CI 52.2*-88.4*);85.6%* (95% CI 78.9*-90.9*)
Krüger, L.J., et al.;Germany;intermediate concern;yes;fresh;NP/OP;727;66.7% (95% CI 41.7-84.8);93.1% (95% CI 91-94.8)
;;;;;;;;
Siemens Healthineers, CLINITEST® Rapid COVID-19 Antigen Test;;;;;;;;
Torres, I. et al.;Spain;low concern;yes;fresh;NP;178;80.2% (95% CI 70.9-87.1);100% (95% CI 95.8-100)
Torres, I. et al.;Spain;low concern;yes;fresh;NP;92;60.0% (95% CI 40.7-76.6);100% (95% CI 94.6-100)
Olearo, F., et al.;Germany;intermediate concern;yes;unclear;OP;170;54.9% (95% CI 43.4-65.9);100% (95% CI 96.3-100)
Baro, B., et al.;Spain;intermediate concern;yes;banked;NP;286;51.5% (95% CI 41.3-61.6);98.4% (95% CI 95.3-99.6)
;;;;;;;;
SIENNA, COVID-19 Antigen Rapid Test;;;;;;;;
Bouassa, M.R.S., et al.;France;high concern;no;banked;NP;100;90% (95% CI 84.1-95.9);100% (95% CI 99.9-100)
;;;;;;;;
Sugentech, SGTi-flex COVID-19 Ag;;;;;;;;
Shidlovskaya, E., et al.;Russia;low concern;yes;fresh;NP;106;"78.6% (95% CI 49.2-95.3)
compared to viral culture";"66.3% (95% CI 55.7-75.8)
compared to viral culture"
Shidlovskaya, E., et al.;Russia;low concern;yes;fresh;NP;106;52.6% (95% CI 40.9-64.0);96.4% (95% CI 81.7-99.9)
;;;;;;;;
SureScreen, COVID-19 Rapid Antigen Test Cassette;;;;;;;;
Baro, B., et al.;Spain;intermediate concern;yes;banked;NP;286;28.8% (95% CI 20.2-38.6);97.8% (95% CI 94.5-99.4)